FDA Inspection 1066601 — Shishuka Malhotra MD
The FDA completed an inspection of Shishuka Malhotra MD on September 5, 2018 in North Canton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 5, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- North Canton, OH (United States)
Additional Details
Clinical Investigator (CI)